сhlorpromazine | N05А А01
Solution for injection
Chronic paranoid and hallucinatory paranoidal conditions, psychomotor agitation in patients with schizophrenia (hallucinatory-delusional, hebephrenic and catatonic syndrome), alcohol-induced psychosis, maniacal agitation in patients with manic-depressive psychosis, mental disorders in patients with epilepsy, agitated depression in patients with presenile, manic-depressive psychosis, other diseases, accompanied by agitation, tension. Neurotic disorders accompanied by increased muscle tone. Permanent pain, including causalgia (concomitantly with analgetics), permanent sleep disorders (concomitantly with insomnia medications and ataractic agents). Meniere's disease, vomiting in pregnancy, preventing of vomiting during treatment with antitumor agents and radiation therapy. Dermatological itch. As a component of “lytic cocktail” in anesthesiology.